Abstract

This document was developed by a consensus conference initiated by Kristian Thygesen, MD, and Joseph S. Alpert, MD, after formal approval by Lars Rydén, MD, President of the European Society of Cardiology (ESC), and Arthur Garson, MD, President of the American College of Cardiology (ACC). All of the participants were selected for their expertise in the field they represented, with approximately one-half of the participants selected from each organization. Participants were instructed to review the scientific evidence in their area of expertise and to attend the consensus conference with prepared remarks. The first draft of the document was prepared during the consensus conference itself. Sources of funding appear in Appendix A. The recommendations made in this document represent the attitudes and opinions of the participants at the time of the conference, and these recommendations were revised subsequently. The conclusions reached will undoubtedly need to be revised as new scientific evidence becomes available. This document has been reviewed by members of the ESC Committee for Scientific and Clinical Initiatives and by members of the Board of the ESC who approved the document on April 15, 2000.*

References

1
Bardales
RH
, Hailey LS, Xie SS, Schaefer RF, Hsu S-U. In situ apoptosis assay for the detection of early acute myocardial infarction.
Am J Pathol
 .
1996
;
149
:
821
–829
2
Buja
LM
. Modulation of the myocardial response to injury.
Lab Invest
 .
1998
;
78
:
1345
–1373
3
Fishbein
MC
, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction.
Chest
 .
1978
;
73
:
743
–749
4
Jennings
RB
, Reimer KA. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood.
Circulation
 .
1983
;
68
:
I-25
–36
5
Jennings
RB
, Schaper J, Hill ML, Steenberger CJ, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury: changes in cell volume, electrolytes, metabolites, and ultrastructure.
Circ Res
 .
1985
;
56
:
262
–278
6
Kajstura
J
, Cheng W, Reiss K. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.
Lab Invest
 .
1996
;
74
:
86
–107
7
Mallory
GK
, White PD, Salcedo-Salga J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 cases.
Am Heart J
 .
1939
;
18
:
647
–671
8
Saraste
A
, Pulkki K, Kallajoki M, Hendriksen K, Parvinen M, Voipio-Pulkki L-M. Apoptosis in human acute myocardial infarction.
Circulation
 .
1997
;
95
:
320
–323
1
Alexander
JH
, Sparapani RA, Mahaffey KW. Association between minor elevations of creatine-kinase-MB and mortality in patients with acute coronary syndromes without ST-segment elevation.
JAMA
 .
2000
;
283
:
347
–353
2
Antman
EM
, Grudzien C, Mitchell RN, Sacks DB. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T.
Am Heart J
 .
1997
;
133
:
596
–598
3
Antman
EM
, Tanasijevic MJ, Thompson B. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.
N Engl J Med
 .
1996
;
335
:
1342
–1349
4
Apple
FS
, Falahati A, Paulson PR, Miller E, Sharkey SW. Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I.
Clin Chem
 .
1997
;
43
:
2047
–2051
5
Apple
FS
. Clinical and analytical standardization issues confronting cardiac troponin I.
Clin Chem
 .
1999
;
45
:
18
–20
6
Apple
FS
. Tissue specificity of cardiac troponin I, cardiac troponin T, and creatine kinase MB.
Clin Chim Acta
 .
1999
;
284
:
151
–158
7
Califf
RM
, Abdelmeguid AE, Kuntz RE. Myonecrosis after revascularization procedures.
J Am Coll Cardiol
 .
1998
;
31
:
241
–251
8
Collinson
PO
. Troponin T or troponin I or CK-MB (or none?).
Eur Heart J
 .
1998
;
19
:
N16
–24
9
Gerhardt
W
, Nordin G, Ljungdahl L. Can troponin T replace CK-MB mass as ‘gold standard’ for acute myocardial infarction (‘AMI’).
Scand J Clin Lab Invest
 .
1999
;
59
:
83
–89
10
Hamm
CW
, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I.
N Engl J Med
 .
1997
;
337
:
1648
–1653
11
Hamm
CW
, Heeschen C, Goldman B. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels.
N Engl J Med
 .
1999
;
340
:
1623
–1629
12
Hamm
CW
, Ravkilde J, Gerhardt W. The prognostic value of serum troponin T in unstable angina.
N Engl J Med
 .
1992
;
327
:
146
–150
13
Harrington
RA
, Lincoff AM, Califf RM. Characteristics and consequences of myocardial infarction following percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomomy Trial (CAVEAT).
J Am Coll Cardiol
 .
1995
;
25
:
1693
–1699
14
Ishikawa
Y
, Saffitz JE, Mealman TL, Grace AM, Roberts R. Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma.
Clin Chem
 .
1997
;
43
:
467
–475
15
Lindahl
B
, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease.
Circulation
 .
1996
;
93
:
1651
–1657
16
Ohman
EM
, Armstrong PW, Christenson RH. Cardiac troponin T levels for risk stratification in acute myocardial ischemia.
N Engl J Med
 .
1996
;
335
:
1333
–1341
17
Ottani
F
, Galvani M, Ferrini D. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina.
Am Heart J
 .
1999
;
137
:
284
–291
18
Ravkilde
J
, Horder M, Gerhardt W. Diagnostic performance and prognostic values of serum troponin T in suspected acute myocardial infarction.
Scand J Clin Lab Invest
 .
1993
;
53
:
677
–685
19
Tardiff
BE
, Califf RM, Tcheng JE. Clinical outcomes after detection of elevated enzymes in patients undergoing percutaneous intervention: IMPACT-II trial (Integrilin [eptifibatide] to Minimize Platelet Aggregation and Coronary Thrombosis-II).
J Am Coll Cardiol
 .
1999
;
33
:
88
–96
20
Wu
AHB
, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery disease.
Clin Chem
 .
1999
;
45
:
1104
–1121
21
Zimmerman
J
, Fromm R, Meyer D. Diagnostic marker cooperative study for the diagnosis of myocardial infarction.
Circulation
 .
1999
;
99
:
1671
–1677
1
Anderson
WD
, Wagner NB, Lee KL. Evaluation of a QRS scoring system for estimating myocardial infarct size. VI: Identification of screening criteria for non-acute myocardial infarcts.
Am J Cardiol
 .
1988
;
61
:
729
–733
2
Chou
T
, Knilans T. Myocardial infarction: myocardial injury, and myocardial ischemia. Chou TC, Knilans TK. Electrocardiography in Clinical Practice: Adult and Pediatric. Philadelphia: W.B. Saunders; 1996. p. 121
3
Crow
RS
, Prineas RJ, Jacobs DR, Blackburn H. A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changes.
Am J Cardiol
 .
1989
;
64
:
454
–461
4
Menown
IBA
, MacKenzie G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction.
Eur Heart J
 .
2000
;
21
:
275
–283
5
Pahlm
US
, Chaitman BR, Rautaharju PM, Selvester RH, Wagner GS. Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle.
Am J Cardiol
 .
1998
;
81
:
809
–815
6
Prineas
RJ
, Crow RJ, Blackburn H. Wright J. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston: John Wright, PSG Inc; 1982. p. 1–229
7
Rautaharju
PM
, Park LP, Chaitman BR, Rautaharju F, Zhang ZM. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression.
J Electrocardiol
 .
1998
;
31
:
157
–187
8
Selvester
RH
, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size: the development and application of the system.
Arch Intern Med
 .
1985
;
145
:
1877
–1881
1
Beller
GA
. Assessment of myocardial viability.
Curr Opin Cardiol
 .
1997
;
12
:
459
–467
2
Buda
AJ
. The role of echocardiography in the evaluation of mechanical complications of acute myocardial infarction.
Circulation
 .
1991
;
84
:
I-109
–121
3
Duca
MD
, Giri S, Wu AHB. Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes.
J Nucl Cardiol
 .
1999
;
6
:
570
–576
4
Gibler
WB
, Runyon JP, Levy RC. A rapid diagnostic and treatment center for patients with chest pain in the emergency department.
Ann Emerg Med
 .
1995
;
25
:
1
–8
5
Lieberman
AN
, Weiss JL, Jugdutt BI. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial function in the dog.
Circulation
 .
1981
;
63
:
739
–746
6
Machecourt
J
, Longere P, Fagret D. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect.
J Am Coll Cardiol
 .
1994
;
23
:
1096
–1106
7
Manoury
C
, Chen CC, Chua KB, Thompson CJ. Quantification of left ventricular function with thallium-201 and technetium-99m sestamibi myocardial gated SPECT.
J Nucl Med
 .
1997
;
38
:
958
–961
8
Peels
C
, Visser CA, Funkekupper AJ, Visser FC, Roos JP. Usefulness of two-dimensional echocardiography for immediate detection of myocardial ischemia in the emergency room.
Am J Cardiol
 .
1990
;
65
:
687
–691
9
Sabia
P
, Abbott RD, Afrookteh A, Keller MW, Touchtone DA, Kaul S. Importance to two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms.
Circulation
 .
1991
;
84
:
1615
–1624
10
Saeian
K
, Rhyne TL, Sagar KB. Ultrasonic tissue characterization for diagnosis of acute myocardial infarction in the coronary care unit.
Am J Cardiol
 .
1994
;
74
:
1211
–1215
11
Tatum
JL
, Jesse RL, Kontos MC. Comprehensive strategy for the evaluation and triage of the chest pain patients.
Ann Emerg Med
 .
1997
;
29
:
116
–125
1
Burke
GL
, Edlavitch SA, Crow RS. The effects of diagnostic criteria on trends in coronary heart disease morbidity: the Minnesota Heart Survey.
J Clin Epidemiol
 .
1989
;
42
:
17
–24
2
Gillum
RF
, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke.
Am Heart J
 .
1984
;
108
:
150
–158
3
McGovern
PG
, Pankow JS, Shaha E. Recent trends in acute coronary heart disease—mortality, morbidity, medical care and risk factors.
N Engl J Med
 .
1966
;
334
:
884
–890
4
Rose, GA, Blackburn, H, Cardiovascular survey methods, World Heart Organization, Geneva, Switzerland, 1968
5
Tunstall-Pedoe
H
, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
Circulation
 .
1994
;
90
:
583
–612
6
Weinstein
BJ
, Epstein FH. Comparability of criteria and methods in the epidemiology of cardiovascular disease: report of a survey.
Circulation
 .
1964
;
30
:
643
7
World Health Organization, Working Group on the Establishment of Ischemic Heart Disease Registers, 1971
8
Circulation
 .
1979
;
59
:
607
–609
9
Porela
P
, Helenius H, Pulkki K, Voipio-Pulkki L-M. Epidemiological classification of acute myocardial infarction: time for a change?
Eur Heart J
 .
1999
;
20
:
1459
–1464

Comments

0 Comments